Stocks and Investing Stocks and Investing
Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018

Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $103 on, Jun 4th, 2018


Published on 2024-10-26 05:55:12 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $109 to $103 on, Jun 4th, 2018.

Konstantinos has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Konstantinos's Rating of Hold.



This is the rating of the analyst that currently disagrees with Konstantinos


  • David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $106 on, Monday, April 16th, 2018